Symbols / BDX Stock $152.14 -1.75% Becton, Dickinson and Company

Healthcare • Medical Instruments & Supplies • United States • NYQ
BDX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. Thomas E. Polen Jr.
Exch · Country NYQ · United States
Market Cap 43.28B
Enterprise Value 62.11B
Income 1.76B
Sales 21.92B
FCF (ttm) 3.11B
Book/sh 88.79
Cash/sh 2.64
Employees 70,000
Insider 10d —
IPO Feb 21, 1973
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 68.14%
P/E 24.86
Forward P/E 11.27
PEG 1.18
P/S 1.97
P/B 1.71
P/C —
EV/EBITDA 10.28
EV/Sales 2.83
Quick Ratio 0.37
Current Ratio 1.05
Debt/Eq 77.28
LT Debt/Eq —
EPS (ttm) 6.12
EPS next Y 13.50
EPS Growth 28.60%
Revenue Growth 1.60%
EPS Gr Q/Q 26.10%
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-02-09
ROA 4.08%
ROE 6.96%
ROIC —
Gross Margin 46.78%
Oper. Margin 13.35%
Profit Margin 8.01%
Shs Outstand 284.47M
Shs Float 283.99M
Insider Own 0.40%
Instit Own 96.41%
Short Float 2.87%
Short Ratio 3.06
Short Interest 7.21M
52W High 187.35
vs 52W High -18.79%
52W Low 127.59
vs 52W Low 19.24%
Beta 0.35
Impl. Vol. 0.78%
Rel Volume 0.59
Avg Volume 2.91M
Volume 1.73M
Target (mean) $191.46
Tgt Median $190.00
Tgt Low $157.00
Tgt High $225.00
# Analysts 13
Recom Buy
Prev Close $154.85
Price $152.14
Change -1.75%
About

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$191.46
Mean price target
2. Current target
$152.14
Latest analyst target
3. DCF / Fair value
$196.49
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$152.14
Low
$157.00
High
$225.00
Mean
$191.46

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-17 main Piper Sandler Neutral → Neutral $159
2026-03-26 main Piper Sandler Neutral → Neutral $159
2026-03-23 main Argus Research Buy → Buy $180
2026-02-11 main Citigroup Buy → Buy $198
2026-02-10 main JP Morgan Neutral → Neutral $175
2026-02-10 main Jefferies Buy → Buy $190
2026-02-10 main RBC Capital Sector Perform → Sector Perform $172
2026-02-10 main Citigroup Buy → Buy $232
2026-02-10 reit Piper Sandler Neutral → Neutral $170
2026-02-10 main Wells Fargo Equal-Weight → Equal-Weight $157
2026-01-28 main Piper Sandler Neutral → Neutral $205
2026-01-07 main Stifel Buy → Buy $215
2026-01-05 main B of A Securities Neutral → Neutral $207
2025-12-17 main RBC Capital Sector Perform → Sector Perform $210
2025-12-02 main Morgan Stanley Overweight → Overweight $210
2025-11-07 main RBC Capital Sector Perform → Sector Perform $202
2025-11-07 main Piper Sandler Neutral → Neutral $190
2025-10-16 reit RBC Capital Sector Perform → Sector Perform $211
2025-09-25 init RBC Capital — → Sector Perform $211
2025-08-11 main Morgan Stanley Overweight → Overweight $197
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-26 FELD MICHAEL Officer — 75 $156.83 $11,762
2026-03-16 MINNIX LANESHA General Counsel — 7,492 $0.00 $0
2026-03-02 SPIKNER PAMELA L Officer — 931 $0.00 $0
2026-03-02 ROQUE VITOR Chief Financial Officer — 931 $0.00 $0
2026-02-26 FELD MICHAEL Officer — 75 $181.84 $13,638
2026-02-18 SCOTT BERTRAM LEE Director — 953 $182.61 $174,027
2026-01-27 RING TIMOTHY M Director — 1,098 $0.00 $0
2026-01-27 HUFFINES ROBERT LUTHER Director — 1,098 $0.00 $0
2026-01-27 WRIGHT JACQUELINE Director — 1,098 $0.00 $0
2026-01-27 BYINGTON CARRIE L Director — 1,098 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Revenue
21,840.00
+8.24%
20,178.00
+4.16%
19,372.00
+2.66%
18,870.00
Operating Revenue
21,840.00
+8.24%
20,178.00
+4.16%
19,372.00
+2.66%
18,870.00
Cost Of Revenue
11,915.00
+7.80%
11,053.00
-1.33%
11,202.00
+7.78%
10,393.00
Reconciled Cost Of Revenue
11,915.00
+7.80%
11,053.00
-1.33%
11,202.00
+7.78%
10,393.00
Gross Profit
9,925.00
+8.77%
9,125.00
+11.69%
8,170.00
-3.62%
8,477.00
Operating Expense
6,939.00
+10.69%
6,269.00
+9.10%
5,746.00
-4.27%
6,002.00
Research And Development
1,265.00
+6.30%
1,190.00
-3.80%
1,237.00
-1.51%
1,256.00
Selling General And Administration
5,278.00
+8.67%
4,857.00
+2.92%
4,719.00
+0.21%
4,709.00
Selling And Marketing Expense
—
—
—
—
General And Administrative Expense
—
—
—
—
Salaries And Wages
—
—
—
—
Other Operating Expenses
396.00
+78.38%
222.00
+205.71%
-210.00
-667.57%
37.00
Total Expenses
18,854.00
+8.84%
17,322.00
+2.21%
16,948.00
+3.37%
16,395.00
Operating Income
2,986.00
+4.55%
2,856.00
+17.82%
2,424.00
-2.06%
2,475.00
Total Operating Income As Reported
2,579.00
+7.59%
2,397.00
+13.55%
2,111.00
-7.49%
2,282.00
EBITDA
4,956.00
+2.84%
4,819.00
+9.47%
4,402.00
-0.18%
4,410.00
Normalized EBITDA
5,416.00
+1.82%
5,319.00
+11.88%
4,754.00
+1.39%
4,689.00
Reconciled Depreciation
2,462.00
+7.70%
2,286.00
-0.09%
2,288.00
+2.65%
2,229.00
EBIT
2,494.00
-1.54%
2,533.00
+19.82%
2,114.00
-3.07%
2,181.00
Total Unusual Items
-460.00
+8.00%
-500.00
-42.05%
-352.00
-26.16%
-279.00
Total Unusual Items Excluding Goodwill
-460.00
+8.00%
-500.00
-42.05%
-352.00
-26.16%
-279.00
Special Income Charges
-408.00
+10.92%
-458.00
-46.33%
-313.00
-44.91%
-216.00
Other Special Charges
—
—
—
24.00
Restructuring And Mergern Acquisition
408.00
-10.92%
458.00
+46.33%
313.00
+63.02%
192.00
Net Income
1,678.00
-1.58%
1,705.00
+14.89%
1,484.00
-16.58%
1,779.00
Pretax Income
1,881.00
-6.18%
2,005.00
+20.64%
1,662.00
-6.79%
1,783.00
Net Non Operating Interest Income Expense
-575.00
-57.53%
-365.00
+9.43%
-403.00
-5.50%
-382.00
Interest Expense Non Operating
613.00
+16.10%
528.00
+16.81%
452.00
+13.57%
398.00
Net Interest Income
-575.00
-57.53%
-365.00
+9.43%
-403.00
-5.50%
-382.00
Interest Expense
613.00
+16.10%
528.00
+16.81%
452.00
+13.57%
398.00
Interest Income Non Operating
38.00
-76.69%
163.00
+232.65%
49.00
+206.25%
16.00
Interest Income
38.00
-76.69%
163.00
+232.65%
49.00
+206.25%
16.00
Other Income Expense
-531.00
-9.26%
-486.00
-35.38%
-359.00
-16.56%
-308.00
Other Non Operating Income Expenses
-71.00
-607.14%
14.00
+300.00%
-7.00
+75.86%
-29.00
Gain On Sale Of Security
-52.00
-23.81%
-42.00
-7.69%
-39.00
+38.10%
-63.00
Tax Provision
203.00
-32.33%
300.00
+127.27%
132.00
-10.81%
148.00
Tax Rate For Calcs
0.00
-28.00%
0.00
+89.87%
0.00
-4.82%
0.00
Tax Effect Of Unusual Items
-49.68
+33.76%
-75.00
-169.71%
-27.81
-20.08%
-23.16
Net Income Including Noncontrolling Interests
1,678.00
-1.58%
1,705.00
+14.89%
1,484.00
-16.58%
1,779.00
Net Income From Continuing Operation Net Minority Interest
1,678.00
-1.58%
1,705.00
+11.44%
1,530.00
-6.42%
1,635.00
Net Income From Continuing And Discontinued Operation
1,678.00
-1.58%
1,705.00
+14.89%
1,484.00
-16.58%
1,779.00
Net Income Continuous Operations
1,678.00
-1.58%
1,705.00
+11.44%
1,530.00
-6.42%
1,635.00
Net Income Discontinuous Operations
0.00
0.00
+100.00%
-46.00
-131.94%
144.00
Normalized Income
2,088.32
-1.96%
2,130.00
+14.87%
1,854.19
-1.94%
1,890.84
Net Income Common Stockholders
1,678.00
-1.58%
1,705.00
+19.73%
1,424.00
-15.69%
1,689.00
Diluted EPS
5.82
-1.85%
5.93
+20.04%
4.94
-15.99%
5.88
Basic EPS
5.83
-2.18%
5.96
+19.92%
4.97
-16.19%
5.93
Basic Average Shares
287.65
-0.73%
289.76
+1.22%
286.28
+0.45%
285.00
Diluted Average Shares
288.51
-0.86%
291.01
+0.91%
288.39
+0.36%
287.36
Diluted NI Availto Com Stockholders
1,678.00
-1.58%
1,705.00
+19.73%
1,424.00
-15.69%
1,689.00
Preferred Stock Dividends
—
—
60.00
-33.33%
90.00
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Assets
55,325.00
-3.42%
57,286.00
+8.54%
52,780.00
-0.29%
52,934.00
Current Assets
9,255.00
-11.59%
10,468.00
+20.65%
8,676.00
+6.57%
8,141.00
Cash Cash Equivalents And Short Term Investments
649.00
-69.98%
2,162.00
+51.83%
1,424.00
+40.43%
1,014.00
Cash And Cash Equivalents
641.00
-62.67%
1,717.00
+21.26%
1,416.00
+40.76%
1,006.00
Other Short Term Investments
8.00
-98.20%
445.00
+5462.50%
8.00
+0.00%
8.00
Receivables
2,994.00
-1.29%
3,033.00
+19.69%
2,534.00
+15.65%
2,191.00
Accounts Receivable
2,994.00
-1.29%
3,033.00
+19.69%
2,534.00
+15.65%
2,191.00
Gross Accounts Receivable
3,088.00
-0.77%
3,112.00
+19.01%
2,615.00
—
Allowance For Doubtful Accounts Receivable
-94.00
-18.99%
-79.00
+2.47%
-81.00
—
Inventory
3,894.00
+1.33%
3,843.00
+17.42%
3,273.00
+1.52%
3,224.00
Raw Materials
860.00
+7.10%
803.00
+12.46%
714.00
+0.99%
707.00
Work In Process
490.00
+10.61%
443.00
+16.27%
381.00
-4.03%
397.00
Finished Goods
2,544.00
-2.04%
2,597.00
+19.24%
2,178.00
+2.74%
2,120.00
Prepaid Assets
—
—
—
1,559.00
Restricted Cash
210.00
+51.08%
139.00
+113.85%
65.00
-57.52%
153.00
Assets Held For Sale Current
—
—
—
0.00
Other Current Assets
1,508.00
+16.81%
1,291.00
-6.45%
1,380.00
-11.48%
1,559.00
Total Non Current Assets
46,069.00
-1.60%
46,818.00
+6.15%
44,104.00
-1.53%
44,790.00
Net PPE
6,997.00
+2.58%
6,821.00
+4.03%
6,557.00
+9.07%
6,012.00
Gross PPE
15,113.00
+5.11%
14,378.00
+5.89%
13,578.00
+9.38%
12,414.00
Accumulated Depreciation
-8,116.00
-7.40%
-7,557.00
-7.63%
-7,021.00
-9.67%
-6,402.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
128.00
-0.78%
129.00
-1.53%
131.00
+3.15%
127.00
Buildings And Improvements
3,895.00
+4.34%
3,733.00
+5.54%
3,537.00
+8.76%
3,252.00
Machinery Furniture Equipment
10,759.00
+5.51%
10,197.00
+6.12%
9,609.00
+9.58%
8,769.00
Other Properties
—
-1.00
—
1.00
Leases
331.00
+3.44%
320.00
+6.31%
301.00
+13.16%
266.00
Goodwill And Other Intangible Assets
36,016.00
-3.65%
37,382.00
+5.39%
35,469.00
-3.96%
36,930.00
Goodwill
26,612.00
+0.56%
26,465.00
+7.92%
24,522.00
-0.40%
24,621.00
Other Intangible Assets
9,404.00
-13.86%
10,917.00
-0.27%
10,947.00
-11.07%
12,309.00
Other Non Current Assets
3,056.00
+16.86%
2,615.00
+25.84%
2,078.00
+12.45%
1,848.00
Total Liabilities Net Minority Interest
29,935.00
-4.66%
31,397.00
+16.36%
26,983.00
-2.42%
27,652.00
Current Liabilities
8,313.00
-7.18%
8,956.00
+34.86%
6,641.00
-14.98%
7,811.00
Payables And Accrued Expenses
6,752.00
-0.50%
6,786.00
+23.40%
5,499.00
-2.36%
5,632.00
Payables
2,303.00
+11.58%
2,064.00
+15.96%
1,780.00
-4.09%
1,856.00
Accounts Payable
1,974.00
+4.11%
1,896.00
+15.54%
1,641.00
-3.41%
1,699.00
Current Accrued Expenses
4,449.00
-5.78%
4,722.00
+26.97%
3,719.00
-1.51%
3,776.00
Employee Benefits
1,069.00
+13.48%
942.00
-7.92%
1,023.00
+13.41%
902.00
Total Tax Payable
329.00
+95.83%
168.00
+20.86%
139.00
-11.46%
157.00
Income Tax Payable
329.00
+95.83%
168.00
+20.86%
139.00
-11.46%
157.00
Current Debt And Capital Lease Obligation
1,560.00
-28.11%
2,170.00
+90.18%
1,141.00
-47.64%
2,179.00
Current Debt
1,560.00
-28.11%
2,170.00
+90.18%
1,141.00
-47.64%
2,179.00
Other Current Borrowings
705.00
-60.17%
1,770.00
+55.13%
1,141.00
-41.46%
1,949.00
Other Current Liabilities
1.00
—
1.00
—
Total Non Current Liabilities Net Minority Interest
21,622.00
-3.65%
22,441.00
+10.32%
20,342.00
+2.53%
19,841.00
Liabilities Heldfor Sale Non Current
—
—
—
0.00
Long Term Debt And Capital Lease Obligation
17,621.00
-1.78%
17,940.00
+21.73%
14,738.00
+6.14%
13,886.00
Long Term Debt
17,621.00
-1.78%
17,940.00
+21.73%
14,738.00
+6.14%
13,886.00
Non Current Deferred Liabilities
—
—
—
5,052.00
Non Current Deferred Taxes Liabilities
—
—
—
5,052.00
Other Non Current Liabilities
2,932.00
-17.62%
3,559.00
-22.31%
4,581.00
-9.34%
5,053.00
Stockholders Equity
25,390.00
-1.93%
25,889.00
+0.36%
25,797.00
+2.04%
25,282.00
Common Stock Equity
25,390.00
-1.93%
25,889.00
+0.36%
25,797.00
+2.05%
25,280.00
Capital Stock
371.00
+0.00%
371.00
+0.00%
371.00
+1.09%
367.00
Common Stock
371.00
+0.00%
371.00
+0.00%
371.00
+1.64%
365.00
Preferred Stock
—
—
0.00
-100.00%
2.00
Share Issued
370.59
+0.00%
370.59
+0.00%
370.59
+1.63%
364.64
Ordinary Shares Number
285.40
-1.28%
289.10
-0.44%
290.39
+2.48%
283.36
Treasury Shares Number
85.19
+4.54%
81.49
+1.61%
80.20
-1.33%
81.28
Additional Paid In Capital
20,075.00
+0.91%
19,893.00
+0.88%
19,720.00
+0.85%
19,553.00
Retained Earnings
16,622.00
+2.99%
16,139.00
+3.89%
15,535.00
+2.49%
15,157.00
Gains Losses Not Affecting Retained Earnings
-1,895.00
-9.41%
-1,732.00
-11.89%
-1,548.00
-4.03%
-1,488.00
Treasury Stock
9,808.00
+11.37%
8,807.00
+6.04%
8,305.00
-0.30%
8,330.00
Other Equity Adjustments
-1,895.00
-9.41%
-1,732.00
-11.89%
-1,548.00
-4.03%
-1,488.00
Total Equity Gross Minority Interest
25,390.00
-1.93%
25,889.00
+0.36%
25,797.00
+2.04%
25,282.00
Total Capitalization
43,011.00
-1.87%
43,829.00
+8.13%
40,535.00
+3.49%
39,168.00
Working Capital
942.00
-37.70%
1,512.00
-25.70%
2,035.00
+516.67%
330.00
Invested Capital
44,571.00
-3.10%
45,999.00
+10.37%
41,676.00
+0.80%
41,345.00
Total Debt
19,181.00
-4.62%
20,110.00
+26.65%
15,879.00
-1.16%
16,065.00
Net Debt
18,540.00
+0.80%
18,393.00
+27.17%
14,463.00
-3.96%
15,059.00
Net Tangible Assets
-10,626.00
+7.54%
-11,493.00
-18.83%
-9,672.00
+16.96%
-11,648.00
Tangible Book Value
-10,626.00
+7.54%
-11,493.00
-18.83%
-9,672.00
+16.98%
-11,650.00
Commercial Paper
855.00
+113.75%
400.00
0.00
-100.00%
230.00
Other Equity Interest
25.00
+0.00%
25.00
+4.17%
24.00
+4.35%
23.00
Preferred Stock Equity
—
—
—
2.00
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Operating Cash Flow
3,431.00
-9.64%
3,797.00
+27.03%
2,989.00
+13.52%
2,633.00
Cash Flow From Continuing Operating Activities
3,431.00
-10.72%
3,843.00
+28.53%
2,990.00
+21.05%
2,470.00
Cash From Discontinued Operating Activities
0.00
+100.00%
-46.00
-4500.00%
-1.00
-100.61%
163.00
Net Income From Continuing Operations
1,678.00
-1.58%
1,705.00
+11.44%
1,530.00
-6.42%
1,635.00
Depreciation Amortization Depletion
2,462.00
+7.70%
2,286.00
-0.09%
2,288.00
+2.65%
2,229.00
Depreciation And Amortization
2,462.00
+7.70%
2,286.00
-0.09%
2,288.00
+2.65%
2,229.00
Other Non Cash Items
284.00
+169.78%
-407.00
-226.79%
321.00
+473.21%
56.00
Pension And Employee Benefit Expense
23.00
+132.86%
-70.00
-162.50%
112.00
+303.64%
-55.00
Stock Based Compensation
258.00
+4.45%
247.00
-4.63%
259.00
+11.16%
233.00
Deferred Tax
-474.00
-124.64%
-211.00
+66.08%
-622.00
-418.33%
-120.00
Deferred Income Tax
-474.00
-124.64%
-211.00
+66.08%
-622.00
-418.33%
-120.00
Operating Gains Losses
23.00
+132.86%
-70.00
+55.13%
-156.00
-183.64%
-55.00
Change In Working Capital
-800.00
-373.04%
293.00
+146.51%
-630.00
+58.22%
-1,508.00
Change In Receivables
71.00
+115.67%
-453.00
-56.21%
-290.00
-1006.25%
32.00
Changes In Account Receivables
71.00
+115.67%
-453.00
-56.21%
-290.00
-1006.25%
32.00
Change In Inventory
-410.00
-518.37%
98.00
+753.33%
-15.00
+97.62%
-631.00
Change In Prepaid Assets
-276.00
-1300.00%
23.00
-88.02%
192.00
+144.04%
-436.00
Change In Payables And Accrued Expense
-185.00
-129.60%
625.00
+220.89%
-517.00
-9.30%
-473.00
Change In Payable
-185.00
-129.60%
625.00
+220.89%
-517.00
-9.30%
-473.00
Change In Account Payable
-185.00
-129.60%
625.00
+220.89%
-517.00
-9.30%
-473.00
Investing Cash Flow
-818.00
+85.17%
-5,514.00
-670.11%
-716.00
+77.84%
-3,231.00
Cash Flow From Continuing Investing Activities
-818.00
+85.17%
-5,514.00
-670.11%
-716.00
+77.76%
-3,220.00
Cash From Discontinued Investing Activities
—
0.00
0.00
+100.00%
-11.00
Capital Expenditure
-760.00
-4.83%
-725.00
+17.05%
-874.00
+10.17%
-973.00
Capital Expenditure Reported
-760.00
-4.83%
-725.00
+17.05%
-874.00
+10.17%
-973.00
Net Investment Purchase And Sale
422.00
+200.24%
-421.00
0.00
0.00
Purchase Of Investment
—
-421.00
0.00
0.00
Net Business Purchase And Sale
0.00
+100.00%
-3,924.00
-826.67%
540.00
+126.09%
-2,070.00
Purchase Of Business
0.00
+100.00%
-3,924.00
0.00
+100.00%
-2,070.00
Gain Loss On Sale Of Business
0.00
0.00
+100.00%
-268.00
0.00
Net Other Investing Changes
-480.00
-8.11%
-444.00
-16.23%
-382.00
-115.82%
-177.00
Financing Cash Flow
-3,617.00
-273.39%
2,086.00
+206.59%
-1,957.00
-231.13%
-591.00
Cash Flow From Continuing Financing Activities
-3,617.00
-273.39%
2,086.00
+206.59%
-1,957.00
-165.90%
-736.00
Net Issuance Payments Of Debt
-1,334.00
-135.34%
3,775.00
+622.13%
-723.00
-826.92%
-78.00
Issuance Of Debt
0.00
-100.00%
4,517.00
+171.78%
1,662.00
+234.41%
497.00
Repayment Of Debt
-1,789.00
-56.65%
-1,142.00
+47.01%
-2,155.00
-167.70%
-805.00
Long Term Debt Issuance
0.00
-100.00%
4,517.00
+171.78%
1,662.00
+234.41%
497.00
Long Term Debt Payments
-1,789.00
-56.65%
-1,142.00
+47.01%
-2,155.00
-167.70%
-805.00
Net Long Term Debt Issuance
-1,789.00
-153.01%
3,375.00
+784.58%
-493.00
-60.06%
-308.00
Net Short Term Debt Issuance
455.00
+13.75%
400.00
+273.91%
-230.00
-200.00%
230.00
Net Common Stock Issuance
-1,000.00
-100.00%
-500.00
0.00
+100.00%
-500.00
Common Stock Payments
—
—
—
-500.00
Common Stock Dividend Paid
-1,196.00
-8.73%
-1,100.00
+1.26%
-1,114.00
-2.96%
-1,082.00
Cash Dividends Paid
-1,196.00
-8.73%
-1,100.00
+1.26%
-1,114.00
-2.96%
-1,082.00
Repurchase Of Capital Stock
—
—
—
-500.00
Net Other Financing Charges
-87.00
+2.25%
-89.00
+25.83%
-120.00
-112.99%
924.00
Changes In Cash
-1,005.00
-370.89%
371.00
+17.03%
317.00
+126.68%
-1,188.00
Effect Of Exchange Rate Changes
0.00
-100.00%
4.00
-20.00%
5.00
+111.11%
-45.00
Beginning Cash Position
1,856.00
+25.32%
1,481.00
+27.78%
1,159.00
-51.55%
2,392.00
End Cash Position
851.00
-54.15%
1,856.00
+25.32%
1,481.00
+27.78%
1,159.00
Free Cash Flow
2,671.00
-13.05%
3,072.00
+45.25%
2,115.00
+27.41%
1,660.00
Common Stock Issuance
—
—
—
0.00
Excess Tax Benefit From Stock Based Compensation
—
—
19.00
-40.63%
32.00
Issuance Of Capital Stock
—
—
—
0.00
Sale Of Business
0.00
0.00
-100.00%
540.00
0.00
Cash From Discontinued Financing Activities
—
0.00
0.00
-100.00%
145.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category